2 ASX AI shares that could be set to soar in 2024 and beyond

Analysts think these shares with AI exposure are top buys and destined for strong growth.

| More on:
A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The share market has been getting very excited about the artificial intelligence (AI) megatrend this year.

And rightly so. It's no exaggeration to say that AI is going to change the world.

We've only really had a small taste of this in the last few years but expect things to accelerate as AI continues to improve and more money is invested in the space.

The good news for investors is that there are ways to gain exposure to AI with ASX shares.

And I don't mean with supposed AI shares like Brainchip Holdings Ltd (ASX: BRN), which has promised the world and delivered nothing in a market dominated by a US$3 trillion behemoth.

I mean with genuine industry leaders that are leveraging AI to cement their position and drive long-term growth. Let's take a look at two:

Pro Medicus Limited (ASX: PME)

The first ASX AI share to look at is health imaging technology company Pro Medicus,

Goldman Sachs recently spoke about how the company's AI revenues could grow from a small percentage of its overall sales into something significant in the future. It said:

AI opens an incremental US$620mn TAM today (growing at a +34.7% CAGR) with radiology receiving the majority (c.80%) of recent FDA AI algorithm clearance. We believe PME is well positioned to take share as the incumbent viewing platform across many large, and likely early adopters of new technology.

PME is generating revenue from its Visage breast density AI algorithm (developed via a partnership with Yale) today, and we see the potential value for AI to be significant with adoption driven by improved accuracy and clinical outcomes. We forecast AI to comprise 9% of PME's revenue by FY30E (from <1% in FY25E), with upside if PME achieves faster AI attach penetration, higher price per scan, and a greater proportion of algorithms developed in-house where no royalties are paid to a partner.

Goldman has a buy rating and $136.00 price target on its shares.

NextDC Ltd (ASX: NXT)

Another ASX AI share to look at is data centre operator NextDC. While it isn't necessarily offering AI services, it is servicing the huge data centre demand for capacity that AI needs to function.

In April, Goldman Sachs commented on this. It said:

NextDC believes AI is driving global data centre growth from 15% to 19% with Australia and broader APAC remaining well-positioned for growth and the fastest growing region. AI is increasing average power density racks (kW/Rack) growing 2.5x to c80-100kW. NXT are seeing demand pipeline for singular deals in the vicinity of 50-100MW and see market growth accelerating. AI demand is also stemming from a 40%/60% mix from inference/training, with upside for inference to reach 70%.

The broker currently has a buy rating and $18.59 price target on its shares. Though, it is worth noting that other brokers are even more bullish. For example, Morgan Stanley has an overweight rating and $20.00 price target.

Motley Fool contributor James Mickleboro has positions in Nextdc and Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

A warehouse worker is standing next to a shelf and using a digital tablet.
Technology Shares

Is WiseTech shaping up as a bargain after its steep decline?

WiseTech shares have pulled back sharply in recent months, giving up a fair bit of the momentum they built earlier…

Read more »

discount asx shares represented by gold baloons in the form of thirty per cent.
Technology Shares

When a top ASX stock falls 30%, it gets my attention. Here's why

The recent share price fall has been hard to ignore, which raises the question of whether the market has overreacted…

Read more »

A man sits in casual clothes in front of a computer amid graphic images of data superimposed on the image, as though he is engaged in IT or hacking activities.
Technology Shares

Megaport shares tipped to jump another 60%: Here's why

Here's what will drive the shares higher over the next months.

Read more »

excited woman looking at ASX share price on computer screen
Technology Shares

4 reasons to buy this ASX 300 tech share today

A leading investment expert forecasts more outperformance from this ASX tech share.

Read more »

person sitting at outdoor table looking at mobile phone and credit card.
Technology Shares

Investors should put these 2 top ASX tech shares on the watchlist

These technology investments could deliver exciting growth.

Read more »

A woman scratches her head in dismay as she looks at chaotic scene at a data centre
Opinions

NextDC shares drop 23% from their peak: Buying opportunity or sign to sell-up?

The tech stock has suffered amid the sector-wide sell off over the past couple of months.

Read more »

Rugby player runs with the ball as four tacklers try to stop him.
Technology Shares

Can this ASX tech stock rise again after last month's 22% tumble?

Brokers think this share can recover, due to its global position.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Broker Notes

3 reasons this ASX 300 tech stock is forecast to leap 83% in 2026

A leading broker expects some outsized returns from this ASX 300 tech share. Let’s see why.

Read more »